Champions' human cancer cell lines allow for the evaluation of your single agent or combination therapeutics to pinpoint responders and non-responders to enable indication selection and target validation.
Standard of care, as well as various therapeutic modalities, have been assessed in vitro and data is available in Lumin. With a deep molecular characterization, which includes proteomics and phospho-proteomics data, Champions' cell line assays are the ideal platform to derive meaningful insights and plan the next phases of your preclinical program.
The Cell Line Panel VitroScreen is Champions' continuously enrolling in vitro screening platform featuring over 100 well-characterized human cancer cell lines. Assess therapeutic efficacy and potency in this high-throughput screening platform.
Champions' Lumin offers access to our multi-omic characterization data including NGS, proteomics, phospho-proteomics, clinical annotation, and in vivo and ex vivo standard of care assessments for each of our PDX models and cell lines.
